In patients with severe community-acquired pneumonia and in mice with acute lung inflammation, circulating BTLA+CD4+ lymphocyte proportions markedly increased, whereas agonistic anti-BTLA antibody reduced the activation of the NF-κB pathway and attenuated the inflammatory responses (95). The gene discussed is BTLA; the disease is inflammatory response.